Annual Net Income
-$29.07 M
+$87.00 K+0.30%
December 31, 2023
Summary
- As of February 6, 2025, TRVI annual net profit is -$29.07 million, with the most recent change of +$87.00 thousand (+0.30%) on December 31, 2023.
- During the last 3 years, TRVI annual net income has risen by +$3.69 million (+11.27%).
- TRVI annual net income is now -126.01% below its all-time high of -$12.86 million, reached on December 31, 2017.
Performance
TRVI Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$13.24 M
-$890.00 K-7.21%
September 30, 2024
Summary
- As of February 6, 2025, TRVI quarterly net profit is -$13.24 million, with the most recent change of -$890.00 thousand (-7.21%) on September 30, 2024.
- Over the past year, TRVI quarterly net income has dropped by -$5.42 million (-69.31%).
- TRVI quarterly net income is now -226.88% below its all-time high of -$4.05 million, reached on March 31, 2018.
Performance
TRVI Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$44.32 M
-$5.54 M-14.30%
September 30, 2024
Summary
- As of February 6, 2025, TRVI TTM net profit is -$44.32 million, with the most recent change of -$5.54 million (-14.30%) on September 30, 2024.
- Over the past year, TRVI TTM net income has dropped by -$15.25 million (-52.48%).
- TRVI TTM net income is now -993.98% below its all-time high of -$4.05 million, reached on March 31, 2018.
Performance
TRVI TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
TRVI Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.3% | -69.3% | -52.5% |
| 3 y3 years | +11.3% | -82.5% | -26.8% |
| 5 y5 years | -41.5% | -79.8% | -70.1% |
TRVI Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +14.4% | -140.5% | at low | -65.7% | at low |
| 5 y | 5-year | -11.6% | +14.4% | -140.5% | at low | -70.1% | at low |
| alltime | all time | -126.0% | +14.4% | -226.9% | at low | -994.0% | at low |
Trevi Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.24 M(+7.2%) | -$44.32 M(+14.3%) |
| Jun 2024 | - | -$12.35 M(+13.3%) | -$38.77 M(+15.5%) |
| Mar 2024 | - | -$10.90 M(+39.4%) | -$33.57 M(+15.5%) |
| Dec 2023 | -$29.07 M(-0.3%) | -$7.82 M(+1.6%) | -$29.07 M(+8.7%) |
| Sep 2023 | - | -$7.70 M(+7.7%) | -$26.75 M(-2.1%) |
| Jun 2023 | - | -$7.14 M(+11.6%) | -$27.32 M(-3.2%) |
| Mar 2023 | - | -$6.40 M(+16.3%) | -$28.22 M(-3.2%) |
| Dec 2022 | -$29.15 M(-14.1%) | -$5.50 M(-33.4%) | -$29.15 M(-9.4%) |
| Sep 2022 | - | -$8.27 M(+2.7%) | -$32.17 M(+3.2%) |
| Jun 2022 | - | -$8.05 M(+9.9%) | -$31.16 M(-5.3%) |
| Mar 2022 | - | -$7.33 M(-14.0%) | -$32.90 M(-3.1%) |
| Dec 2021 | -$33.94 M | -$8.52 M(+17.4%) | -$33.94 M(-2.9%) |
| Sep 2021 | - | -$7.25 M(-25.9%) | -$34.94 M(-0.4%) |
| Jun 2021 | - | -$9.79 M(+17.0%) | -$35.07 M(+7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$8.37 M(-12.1%) | -$32.66 M(-0.3%) |
| Dec 2020 | -$32.76 M(+25.8%) | -$9.52 M(+29.1%) | -$32.76 M(+10.0%) |
| Sep 2020 | - | -$7.38 M(-0.1%) | -$29.77 M(+0.0%) |
| Jun 2020 | - | -$7.38 M(-12.9%) | -$29.76 M(+0.1%) |
| Mar 2020 | - | -$8.47 M(+29.6%) | -$29.72 M(+14.1%) |
| Dec 2019 | -$26.05 M(+26.8%) | -$6.54 M(-11.2%) | -$26.05 M(+2.2%) |
| Sep 2019 | - | -$7.37 M(+0.3%) | -$25.50 M(+7.2%) |
| Jun 2019 | - | -$7.35 M(+53.0%) | -$23.78 M(+11.7%) |
| Mar 2019 | - | -$4.80 M(-19.7%) | -$21.30 M(+3.7%) |
| Dec 2018 | -$20.55 M(+59.8%) | -$5.98 M(+5.8%) | -$20.55 M(+41.1%) |
| Sep 2018 | - | -$5.65 M(+16.4%) | -$14.56 M(+63.5%) |
| Jun 2018 | - | -$4.86 M(+19.9%) | -$8.91 M(+119.9%) |
| Mar 2018 | - | -$4.05 M | -$4.05 M |
| Dec 2017 | -$12.86 M | - | - |
FAQ
- What is Trevi Therapeutics annual net profit?
- What is the all time high annual net income for Trevi Therapeutics?
- What is Trevi Therapeutics annual net income year-on-year change?
- What is Trevi Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Trevi Therapeutics?
- What is Trevi Therapeutics quarterly net income year-on-year change?
- What is Trevi Therapeutics TTM net profit?
- What is the all time high TTM net income for Trevi Therapeutics?
- What is Trevi Therapeutics TTM net income year-on-year change?
What is Trevi Therapeutics annual net profit?
The current annual net income of TRVI is -$29.07 M
What is the all time high annual net income for Trevi Therapeutics?
Trevi Therapeutics all-time high annual net profit is -$12.86 M
What is Trevi Therapeutics annual net income year-on-year change?
Over the past year, TRVI annual net profit has changed by +$87.00 K (+0.30%)
What is Trevi Therapeutics quarterly net profit?
The current quarterly net income of TRVI is -$13.24 M
What is the all time high quarterly net income for Trevi Therapeutics?
Trevi Therapeutics all-time high quarterly net profit is -$4.05 M
What is Trevi Therapeutics quarterly net income year-on-year change?
Over the past year, TRVI quarterly net profit has changed by -$5.42 M (-69.31%)
What is Trevi Therapeutics TTM net profit?
The current TTM net income of TRVI is -$44.32 M
What is the all time high TTM net income for Trevi Therapeutics?
Trevi Therapeutics all-time high TTM net profit is -$4.05 M
What is Trevi Therapeutics TTM net income year-on-year change?
Over the past year, TRVI TTM net profit has changed by -$15.25 M (-52.48%)